Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Colorectal Neoplasms

  Free Subscription


Articles published in Br J Surg

Retrieve available abstracts of 212 articles:
HTML format



Single Articles


    December 2024
  1. LUNDSTROM S, Agger E, Lydrup ML, Jorgren F, et al
    Tumour deposit count is an independent prognostic factor in colorectal cancer-a population-based cohort study.
    Br J Surg. 2024;112:znae309.
    PubMed     Abstract available


    October 2024
  2. CAI ZH, Guo YC, Ye K, Xiao Y, et al
    Infrapyloric and gastroepiploic lymph node metastasis in right transverse colon cancer (InCLART study): multicentre, prospective, observational study.
    Br J Surg. 2024;111:znae272.
    PubMed    


    September 2024
  3. WENZELBERG CL, Rogmark P, Ekberg O, Petersson U, et al
    Reinforced tension-line suture after laparotomy: early results of the Rein4CeTo1 randomized clinical trial.
    Br J Surg. 2024;111:znae265.
    PubMed     Abstract available


    August 2024
  4. PAOLUCCI I, Albuquerque Marques Silva J, Lin YM, Laimer G, et al
    Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation.
    Br J Surg. 2024;111:znae165.
    PubMed     Abstract available


  5. SOREIDE K, Kok NFM
    Curative-intent ablation margins (A0) for colorectal liver metastasis: more burning questions.
    Br J Surg. 2024;111:znae184.
    PubMed    


  6. ZUKAUSKAITE K, Horvath A, Gricius Z, Kvietkauskas M, et al
    Impact of mechanical bowel preparation on the gut microbiome of patients undergoing left-sided colorectal cancer surgery: randomized clinical trial.
    Br J Surg. 2024;111:znae213.
    PubMed     Abstract available


  7. VALDMAN A, Marsk R, Karimi M, Asklid D, et al
    Surgical outcomes following total neoadjuvant therapy in rectal cancer with short-course radiotherapy using protons or photons: initial safety data from the PRORECT randomized trial.
    Br J Surg. 2024;111:znae241.
    PubMed    


  8. WILLIAMS H, Yuval JB, Verheij FS, Miranda J, et al
    Baseline MRI predictors of successful organ preservation in the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial.
    Br J Surg. 2024;111:znae246.
    PubMed     Abstract available


  9. OZCAN C, Colak T, Turkmenoglu O, Berkesoglu M, et al
    Impact of small-bite (5 mm) fascial closure on the incidence of incisional hernia following open colorectal cancer surgery: randomized clinical trial.
    Br J Surg. 2024;111:znae189.
    PubMed     Abstract available


  10. BOZKURT E, Sijberden JP, Langella S, Cipriani F, et al
    Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study.
    Br J Surg. 2024;111:znae181.
    PubMed     Abstract available


  11. PEDRAZZANI C, Turri G, Ostuzzi G, Barbui C, et al
    Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Br J Surg. 2024;111:znae209.
    PubMed    


  12. DONNELLY M, Ryan OK, Ryan EJ, Winter DC, et al
    Author response to: Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Br J Surg. 2024;111:znae211.
    PubMed    


    July 2024
  13. MARGONIS GA, Wang JJ, Boerner T, Moretto R, et al
    Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study.
    Br J Surg. 2024;111:znae176.
    PubMed     Abstract available


  14. JOYCE A, Drake TM, Hampson C, Monaghan A, et al
    Comment on: Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study.
    Br J Surg. 2024;111:znae194.
    PubMed    


  15. ROTTOLI M, Spinelli A, Pellino G, Gori A, et al
    Author response to: Comment on: Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study.
    Br J Surg. 2024;111:znae193.
    PubMed    


  16. GUAN X, Zhao X, Jiao S, Hao R, et al
    Circulating immune cell profile in patients with colorectal cancer.
    Br J Surg. 2024;111:znae186.
    PubMed    


    June 2024
  17. BAO QR, Ferrari S, Capelli G, Chiloiro G, et al
    Oncological outcomes of patients not undergoing Total Mesorectal Excision after local excision: rethinking surgical indications.
    Br J Surg. 2024;111:znae144.
    PubMed    


    May 2024
  18. ZAFFARONI G, Mannucci A, Koskenvuo L, de Lacy B, et al
    Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EH
    Br J Surg. 2024;111:znae070.
    PubMed     Abstract available


  19. OLTHOF K, Smit J, Fusaglia M, Kok N, et al
    A surgical navigation system to aid the ablation of vanished colorectal liver metastases.
    Br J Surg. 2024;111:znae110.
    PubMed    


  20. GABRIELE R, Campagnol M, Iannone I, Sapienza P, et al
    Faecal occult blood and sigmoidoscopy data from the Italian national screening programme.
    Br J Surg. 2024;111:znae131.
    PubMed    


    April 2024
  21. KRUL MF, Kok NFM, Osmani H, Buisman FE, et al
    Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
    Br J Surg. 2024;111:znae089.
    PubMed     Abstract available


    March 2024
  22. CUK P, Tiskus M, Moller S, Lambertsen KL, et al
    Surgical stress response in robot-assisted versus laparoscopic surgery for colon cancer (SIRIRALS): randomized clinical trial.
    Br J Surg. 2024;111:znae049.
    PubMed     Abstract available


  23. GLYNNE-JONES R, Harrison M
    Colorectal cancer para-aortic lymph node metastases: surgery should not be considered.
    Br J Surg. 2024;111:znad443.
    PubMed    


  24. PEACOCK O
    Colorectal cancer para-aortic lymph node metastases-surgery should be considered.
    Br J Surg. 2024;111:znad445.
    PubMed    


  25. PEREA J, Garcia JL, Corchete LA, Marti M, et al
    Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers.
    Br J Surg. 2024;111:znae041.
    PubMed    


  26. MARTIN-CULLELL B, Virgili AC, Riera P, Fumagalli C, et al
    Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases.
    Br J Surg. 2024;111:znae016.
    PubMed     Abstract available


    January 2024
  27. GOMEZ RUIZ M, Espin-Basany E, Spinelli A, Cagigas Fernandez C, et al
    Author response to: Comment on: Early outcomes from the Minimally Invasive Right Colectomy Anastomosis study (MIRCAST).
    Br J Surg. 2024;111:znad444.
    PubMed    


  28. KELM M, Flemming S
    Comment on: Early outcomes from the Minimally Invasive Right Colectomy Anastomosis Study (MIRCAST).
    Br J Surg. 2024;111:znad440.
    PubMed    


  29. ALISEDA D, Arredondo J, Sanchez-Justicia C, Alvarellos A, et al
    Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis.
    Br J Surg. 2024;111:znae021.
    PubMed     Abstract available


  30. BROWN KGM, Solomon MJ, Sutton PA, Shin JS, et al
    The definition of clear resection margins in locally recurrent rectal cancer-time for consensus.
    Br J Surg. 2024;111:znad450.
    PubMed    


  31. KRON P, Lodge JPA
    Changing perspectives in the treatment of colorectal liver metastases.
    Br J Surg. 2024;111:znad431.
    PubMed    


  32. KUSTERS M
    Lateral pelvic lymph nodes in rectal cancer: a multi-disciplinary team effort is needed to prevent local recurrence.
    Br J Surg. 2024;111:znad449.
    PubMed    


  33. TAYLOR AS, Au S, Krivankova B, Asanai K, et al
    Carbon footprint of laparoscopic right hemicolectomy.
    Br J Surg. 2024;111:znad422.
    PubMed    


  34. SANO S, Fukunaga Y, Sakamoto T, Hiyoshi Y, et al
    Laparoscopic resection for locally advanced rectal cancer: propensity score-matched analysis.
    Br J Surg. 2024;111:znad350.
    PubMed    


  35. AUSTIN KKS, Brown KGM, Solomon MJ
    En bloc lateral pelvic compartment excision during pelvic exenteration: video vignette.
    Br J Surg. 2024;111:znad407.
    PubMed    


  36. DELATTRE F, Trilling B, Sage PY, Bonne A, et al
    Complete mesocolic excision for caecal tumours is overtreatment: COLOC study.
    Br J Surg. 2024;111:znad411.
    PubMed    


  37. SADIEN ID
    Comment on: Non-invasive measurement of intestinal tissue oxygen saturation for evaluation of reconstructed blood flow in rectal cancer surgery: HiSCO-09 study.
    Br J Surg. 2024;111:znad399.
    PubMed    


  38. SHIMOMURA M, Yoshinaka H, Egi H, Shimizu W, et al
    Author response to: Comment on: Non-invasive measurement of intestinal tissue oxygen saturation for evaluation of reconstructed blood flow in rectal cancer surgery: HiSCO-09 study.
    Br J Surg. 2024;111:znad400.
    PubMed    


  39. WU Q, He Y, Wang Z
    Author response: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Br J Surg. 2024;111:znad390.
    PubMed    


  40. ZHANG W, Huang J
    Comment on: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Br J Surg. 2024;111:znad389.
    PubMed    


  41. BRAUN M
    T3N1M0 rectal cancer: the optimal initial management is systemic anti-cancer therapy.
    Br J Surg. 2024;111:znad324.
    PubMed    


  42. NILSSON PJ
    T3 N1 M0 rectal cancer: optimal initial management is total neoadjuvant therapy.
    Br J Surg. 2024;111:znad322.
    PubMed    


  43. ARTHUR C, Teo M
    T3 N1 M0 rectal cancer: the optimal initial management is long-course chemoradiotherapy.
    Br J Surg. 2024;111:znad323.
    PubMed    


  44. HARRIS DA
    T3 N1 M0 rectal cancer: optimal initial management is upfront surgery.
    Br J Surg. 2024;111:znad321.
    PubMed    


  45. BONNE A, Trilling B, Sage PY, Fauconnier J, et al
    Influence of day of surgery on morbidity after laparoscopic colorectal resection for cancer in the era of enhanced recovery after surgery (ERAS).
    Br J Surg. 2024;111:znad387.
    PubMed    


  46. STRIJKER D, Hoogeboom TJ, Meijerink JWJH, Taveirne A, et al
    Multimodal rehabilitation (Fit4Chemo) before and during adjuvant chemotherapy in patients with colonic cancer.
    Br J Surg. 2024;111:znad354.
    PubMed    


  47. BILKHU AS, Wild J, Sagar PM
    Management of retrorectal tumours.
    Br J Surg. 2024;111:znae012.
    PubMed    


    December 2023
  48. GRUTER AAJ, Toorenvliet BR, Belgers EHJ, Belt EJT, et al
    Nationwide standardization of minimally invasive right hemicolectomy for colon cancer and development and validation of a video-based competency assessment tool (the Right study).
    Br J Surg. 2023 Dec 16:znad404. doi: 10.1093.
    PubMed     Abstract available


  49. LYGRE KB, Eide GE, Liedenbaum MH, Augland IMB, et al
    Short and equal vascular stump length after standardized laparoscopic and open surgery with central lymphadenectomy for right-sided colon cancer.
    Br J Surg. 2023 Dec 8:znad410. doi: 10.1093.
    PubMed    


    November 2023
  50. MIZUUCHI Y, Nagayoshi K, Nakamura M, Ikeuchi H, et al
    Prognostic impact of tumour location in stage II/III ulcerative colitis-associated colon cancer: subgroup analysis of a nationwide multicentre retrospective study in Japan.
    Br J Surg. 2023 Nov 25:znad386. doi: 10.1093.
    PubMed    


  51. LEDERHUBER H, Massey LH, Abeysiri S, Roman MA, et al
    Preoperative intravenous iron and the risk of blood transfusion in colorectal cancer surgery: meta-analysis of randomized clinical trials.
    Br J Surg. 2023 Nov 23:znad320. doi: 10.1093.
    PubMed    


  52. ROTTOLI M, Spinelli A, Pellino G, Gori A, et al
    Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study.
    Br J Surg. 2023 Nov 14:znad373. doi: 10.1093.
    PubMed     Abstract available


  53. ZHANG K, Yuan Z, Lu Y, Chen L, et al
    Totally robotic surgery for rectal cancer with the daVinci(R) single-port platform.
    Br J Surg. 2023;110:1890.
    PubMed    


  54. GREIJDANUS NG, Wienholts K, Ubels S, Talboom K, et al
    Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients.
    Br J Surg. 2023;110:1863-1876.
    PubMed     Abstract available


  55. YOSHINAKA H, Shimomura M, Egi H, Shimizu W, et al
    Non-invasive measurement of intestinal tissue oxygen saturation for evaluation of reconstructed blood flow in rectal cancer surgery: HiSCO-09 study.
    Br J Surg. 2023;110:1769-1773.
    PubMed    


  56. VIMALACHANDRAN D
    Neoadjuvant chemotherapy for locally advanced colonic cancer is not ready to be the standard of care.
    Br J Surg. 2023;110:1677-1678.
    PubMed    


  57. MORTON D, Seligmann J
    Neoadjuvant chemotherapy for locally advanced colonic cancer is the standard of care.
    Br J Surg. 2023;110:1679-1680.
    PubMed    


  58. VAUGHAN-SHAW PG, Evans MD
    Neoadjuvant chemotherapy for advanced colonic cancer: standard of care or is the jury still out?
    Br J Surg. 2023;110:1565-1566.
    PubMed    


  59. KIYOZUMI Y, Yamaguchi T, Ichikawa N, Homma S, et al
    Endoscopic Surgical Skill Qualification System: propensity-score matched cohort analysis of accredited supervisors in laparoscopic rectal cancer surgery.
    Br J Surg. 2023;110:1834-1839.
    PubMed     Abstract available


  60. NORDKAMP S, van Rees JM, van den Berg K, Mens DM, et al
    Locally recurrent rectal cancer: oncological outcomes of neoadjuvant chemoradiotherapy with or without induction chemotherapy.
    Br J Surg. 2023;110:1637-1640.
    PubMed    


  61. FRANCIS NK, Penna M, Dritsas S, Kinsey H, et al
    Oncological outcomes after transanal total mesorectal excision for rectal cancer.
    Br J Surg. 2023;110:1614-1617.
    PubMed    


  62. GAO J, Gu X, Pang M, Zhang H, et al
    Risk factors for anastomotic leak and postoperative morbidity after right hemicolectomy for colon cancer: results from a prospective, multi-centre, snapshot study in China.
    Br J Surg. 2023 Nov 7:znad316. doi: 10.1093.
    PubMed     Abstract available


    October 2023
  63. JONES RP, Lee LYW, Corrie PG, Danson S, et al
    Individualized cancer vaccines versus surveillance after adjuvant chemotherapy for surgically resected high-risk stage 2 and stage 3 colorectal cancer: protocol for a randomized trial.
    Br J Surg. 2023 Oct 19:znad332. doi: 10.1093.
    PubMed    


  64. YANG X, Hu Q
    Comment on: Outcomes of laparoscopic versus robotic-assisted resection of T4 rectal cancer: propensity score-matched analysis of a national cancer database.
    Br J Surg. 2023;110:1562.
    PubMed    


  65. VAN EERDEN RAG, de Boer NL, van Kooten JP, Bakkers C, et al
    Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.
    Br J Surg. 2023;110:1502-1510.
    PubMed     Abstract available


    September 2023
  66. KATAOKA K, Takahashi K, Takeuchi J, Ito K, et al
    Author response to: Comment on: Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Br J Surg. 2023;110:1407.
    PubMed    


  67. HANY TS, Jadav AM, Parkin E, Bhowmick AK, et al
    Extraperitoneal approach to left-sided colorectal resections (EXPERTS procedure).
    Br J Surg. 2023;110:1348-1354.
    PubMed    


  68. YANG X, Hu Q
    Comment on: Early outcomes from the Minimally Invasive Right Colectomy Anastomosis Study (MIRCAST).
    Br J Surg. 2023;110:1406.
    PubMed    


  69. EMILE SH, Wexner SD
    Author response to: Comment on: Outcomes of laparoscopic versus robotic-assisted resection of T4 rectal cancer: propensity score-matched analysis of a national cancer database.
    Br J Surg. 2023;110:1405.
    PubMed    


  70. JONES S, Perin G, Balasubramanian S
    Comment on: Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
    Br J Surg. 2023;110:1404.
    PubMed    


  71. DONNELLY M, Ryan OK, Ryan EJ, Creavin B, et al
    Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Br J Surg. 2023;110:1316-1330.
    PubMed     Abstract available


  72. VOIGT KR, Wullaert L, de Graaff MR, Verhoef C, et al
    Association between textbook outcome and long-term survival after surgery for colorectal liver metastases.
    Br J Surg. 2023;110:1284-1287.
    PubMed    


  73. ARJONA-SANCHEZ A
    In favour of prophylactic hyperthermic intraperitoneal chemotherapy for colorectal cancer.
    Br J Surg. 2023 Sep 2:znad279. doi: 10.1093.
    PubMed    


  74. TANIS PJ
    Opposed to prophylactic hyperthermic intraperitoneal chemotherapy for colorectal cancer.
    Br J Surg. 2023 Sep 2:znad280. doi: 10.1093.
    PubMed    


    August 2023
  75. TEMMINK SJD, Peeters KCMJ, Renehan AG, Pares O, et al
    Author response to: Comment on: Outcomes following watch and wait of a clinical complete response in rectal cancer after neoadjuvant treatment: comparison of patients with and without complete response at first reassessment in the International Watch
    Br J Surg. 2023;110:1242.
    PubMed    


  76. GOMEZ RUIZ M, Espin-Basany E, Spinelli A, Cagigas Fernandez C, et al
    Early outcomes from the Minimally Invasive Right Colectomy Anastomosis study (MIRCAST).
    Br J Surg. 2023;110:1153-1160.
    PubMed     Abstract available


  77. MEURETTE G, Faucheron JL, Cotte E, Denost Q, et al
    Low anterior resection syndrome after rectal resection management: multicentre randomized clinical trial of transanal irrigation with a dedicated device (cone catheter) versus conservative bowel management.
    Br J Surg. 2023;110:1092-1095.
    PubMed    


  78. VAN REES JM, Krul MF, Kok NFM, Grunhagen DJ, et al
    Treatment of locally advanced rectal cancer and synchronous liver metastases: multicentre comparison of two treatment strategies.
    Br J Surg. 2023;110:1049-1052.
    PubMed    


    July 2023
  79. SHAH D, Di Re A, Toh JWT
    Aspirin chemoprevention in colorectal cancer: network meta-analysis of low, moderate, and high doses.
    Br J Surg. 2023 Jul 27:znad231. doi: 10.1093.
    PubMed     Abstract available


  80. BEETS GL
    Near-complete response following neoadjuvant therapy in rectal cancer: wait a bit longer?
    Br J Surg. 2023;110:938-939.
    PubMed    


  81. MANENTI A, Caramaschi S, Farinetti A, Manco G, et al
    Comment on: Reconstructive techniques following low anterior resection for carcinoma of the rectum: meta-analysis.
    Br J Surg. 2023;110:1018.
    PubMed    


  82. PEREZ RO, Cerdan-Santacruz C, Sao Juliao GP
    Near-complete response following neoadjuvant therapy in rectal cancer: resect now?
    Br J Surg. 2023;110:936-937.
    PubMed    


  83. GE Y, Zhang S, Zheng M, Zhang W, et al
    Comment on: Reconstructive techniques following low anterior resection for carcinoma of the rectum: meta-analysis.
    Br J Surg. 2023;110:1017.
    PubMed    


  84. NORDKAMP S, Piqeur F, van den Berg K, Tolenaar JL, et al
    Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapy.
    Br J Surg. 2023;110:950-957.
    PubMed     Abstract available


  85. PEACOCK O, Manisundaram N, Kim Y, Konishi T, et al
    Therapeutic lateral pelvic lymph node dissection in rectal cancer: when to dissect? Size is not everything.
    Br J Surg. 2023;110:985-986.
    PubMed    


  86. UUTELA A, Nordin A, Osterlund E, Halonen P, et al
    Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.
    Br J Surg. 2023;110:931-935.
    PubMed    


  87. SIRIWARDENA AK, Serrablo A, Fretland AA, Wigmore SJ, et al
    Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE.
    Br J Surg. 2023 Jul 14:znad124. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  88. KATAOKA K, Takahashi K, Takeuchi J, Ito K, et al
    Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Br J Surg. 2023;110:864-869.
    PubMed     Abstract available


  89. WU Q, Zhou J, Huang J, Deng X, et al
    Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Br J Surg. 2023;110:784-796.
    PubMed     Abstract available


  90. VERWEIJ ME, Franzen J, van Grevenstein WMU, Verkooijen HM, et al
    Timing of rectal cancer surgery after short-course radiotherapy: national database study.
    Br J Surg. 2023;110:839-845.
    PubMed     Abstract available


  91. GERRARD AD, Dunlop MG, Din FVN
    Author response to: Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.
    Br J Surg. 2023 Jun 1:znad121. doi: 10.1093.
    PubMed    


    May 2023
  92. COHEN R, Platell CF, McCoy MJ, Meehan K, et al
    Circulating tumour DNA in colorectal cancer management.
    Br J Surg. 2023 May 16:znad126. doi: 10.1093.
    PubMed    


  93. EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
    Robotic and laparoscopic colectomy: propensity score-matched outcomes from a national cancer database.
    Br J Surg. 2023;110:717-726.
    PubMed     Abstract available


  94. TEMMINK SJD, Peeters KCMJ, Bahadoer RR, Kranenbarg EM, et al
    Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
    Br J Surg. 2023;110:676-684.
    PubMed     Abstract available


  95. BERTELSEN CA, Bianchi PP, Croner R, Kleif J, et al
    Comment on: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:734.
    PubMed    


  96. SO JBY
    Bi-directional chemotherapy for peritoneal metastases.
    Br J Surg. 2023;110:627-628.
    PubMed    


  97. CHONG Y, Perin G, Balasubramanian SP
    Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.
    Br J Surg. 2023 May 8:znad122. doi: 10.1093.
    PubMed    


    April 2023
  98. DOHRN N, Klein MF
    Colorectal cancer: current management and future perspectives.
    Br J Surg. 2023 Apr 20:znad095. doi: 10.1093.
    PubMed    


  99. BENZ SR, Feder IS, Vollmer S, Tam Y, et al
    Author response to: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:621.
    PubMed    


  100. BENZ SR, Feder IS, Vollmer S, Tam Y, et al
    Author response to: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:617.
    PubMed    


  101. AKYOL C, Kuzu MA
    Comment on: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:614.
    PubMed    


    March 2023
  102. CRIPPS P, Scott K, Sekhar H, Harries RL, et al
    Faecal immunochemical testing in symptomatic lower gastrointestinal triage: cohort study of patient acceptability and impact of social deprivation.
    Br J Surg. 2023;110:511-512.
    PubMed    


  103. WANG X
    Comment on: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:520.
    PubMed    


  104. CASHIN PH, Soderstrom M, Blom K, Artursson S, et al
    Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases.
    Br J Surg. 2023 Mar 15:znad066. doi: 10.1093.
    PubMed    



  105. Erratum to: Outcomes of surgical resection in microsatellite instable colorectal cancer after immune checkpoint inhibitor treatment.
    Br J Surg. 2023 Mar 4:znad072. doi: 10.1093.
    PubMed    


    February 2023
  106. WENSINK GE, Bolhuis K, Elferink MAG, Fijneman RJA, et al
    Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases.
    Br J Surg. 2023;110:362-371.
    PubMed     Abstract available


  107. MATHEW A, Ramachandra D, Goyal A, Nariampalli Karthyarth M, et al
    Reconstructive techniques following low anterior resection for carcinoma of the rectum: meta-analysis.
    Br J Surg. 2023;110:313-323.
    PubMed     Abstract available


  108. KITAGUCHI D, Hasegawa H, Teramura K, Ikeda K, et al
    Comparison of postoperative anorectal function between hand-sewn and stapled anastomoses in intersphincteric resection with transanal total mesorectal excision.
    Br J Surg. 2023;110:375-376.
    PubMed    


  109. GERRARD AD, Maeda Y, Miller J, Gunn F, et al
    Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.
    Br J Surg. 2023 Feb 14:znad016. doi: 10.1093.
    PubMed     Abstract available


  110. PEREA J, Winter D
    Early-onset sporadic colorectal cancer: key question of early diagnosis and screening strategies.
    Br J Surg. 2023 Feb 2:znad014. doi: 10.1093.
    PubMed    


    January 2023
  111. EMILE SH, Horesh N, Freund MR, Garoufalia Z, et al
    Outcomes of laparoscopic versus robotic-assisted resection of T4 rectal cancer: propensity score-matched analysis of a national cancer database.
    Br J Surg. 2023;110:242-250.
    PubMed     Abstract available


  112. SERRA-ARACIL X, Mora-Lopez L
    Author response to: Comment on: Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Br J Surg. 2023;110:284.
    PubMed    


  113. ZHAO S, Tong W
    Comment on: Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Br J Surg. 2023;110:283.
    PubMed    


  114. SERRA-ARACIL X, Zarate A, Bargallo J, Gonzalez A, et al
    Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Br J Surg. 2023;110:150-158.
    PubMed     Abstract available


  115. REUVERS JRD, Budding AE, van Egmond M, Stockmann HBAC, et al
    Gut Proteobacteria levels and colorectal surgical infections: SELECT trial.
    Br J Surg. 2023;110:129-132.
    PubMed    



  116. Erratum to: Managing surgical demand when needs outstrip resource: qualitative investigation of colorectal cancer surgery provision in the first wave of the COVID-19 pandemic.
    Br J Surg. 2023 Jan 4:znac459. doi: 10.1093.
    PubMed    


    December 2022
  117. SHUKLA HS, Kumar S, Srivastava A
    Comment on: Incisional hernia following colorectal cancer surgery according to suture technique: Hughes Abdominal Repair Randomized Trial (HART).
    Br J Surg. 2022 Dec 15:znac441. doi: 10.1093.
    PubMed    


  118. ALEXANDRE C, Medhi K, Christelle F, Thierry A, et al
    Outcomes of surgical resection in microsatellite instable colorectal cancer after immune checkpoint inhibitor treatment.
    Br J Surg. 2022 Dec 15:znac425. doi: 10.1093.
    PubMed    


  119. BENZ SR, Feder IS, Vollmer S, Tam Y, et al
    Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2022;110:98-105.
    PubMed     Abstract available


  120. CUSTERS PA, Geubels BM, Beets GL, Lambregts DMJ, et al
    Defining near-complete response following (chemo)radiotherapy for rectal cancer: systematic review.
    Br J Surg. 2022;110:43-49.
    PubMed     Abstract available


  121. MAGHERBI H, Ouadi Y, Brahim MB, Boukriba S, et al
    Colonic lipoma.
    Br J Surg. 2022;110:122.
    PubMed    


    November 2022
  122. STAIGER RD, Rossler F, Kim MJ, Brown C, et al
    Benchmarks in colorectal surgery: multinational study to define quality thresholds in high and low anterior resection.
    Br J Surg. 2022;109:1274-1281.
    PubMed     Abstract available


  123. CONEFREY C, Ochieng C, Hoffman C, Elliott D, et al
    Managing surgical demand when needs outstrip resource: qualitative investigation of colorectal cancer surgery provision in the first wave of the COVID-19 pandemic.
    Br J Surg. 2022 Nov 7. pii: 6806207. doi: 10.1093.
    PubMed     Abstract available



  124. Corrigendum to: Incisional hernia following colorectal cancer surgery according to suture technique: Hughes Abdominal Repair Randomized Trial (HART).
    Br J Surg. 2022 Nov 3. pii: 6794309. doi: 10.1093.
    PubMed    


    October 2022
  125. PANG K, Yang Y, Zhao P, Wu G, et al
    Adding immune checkpoint blockade to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Br J Surg. 2022;109:1178-1179.
    PubMed    


  126. BUETTNER S, Olthof PB, Wang J, Kreis ME, et al
    Author response to: Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:e122.
    PubMed    


  127. LIU QL, Chen HN
    Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:e121.
    PubMed    


  128. FAHIM M, Couwenberg A, Verweij ME, Dijksman LM, et al
    SPONGE-assisted versus Trendelenburg position surgery in laparoscopic sigmoid and rectal cancer surgery (SPONGE trial): randomized clinical trial.
    Br J Surg. 2022;109:1081-1086.
    PubMed     Abstract available


  129. BISSET CN, Ferguson E, MacDermid E, Stein SL, et al
    Exploring variation in surgical practice: does surgeon personality influence anastomotic decision-making?
    Br J Surg. 2022;109:1156-1163.
    PubMed     Abstract available


    September 2022
  130. LAMAZZA A, Fiori E, Carati M, Antoniozzi A, et al
    Endoscopic stenting for left-sided obstructing colorectal cancer.
    Br J Surg. 2022 Sep 27. pii: 6718181. doi: 10.1093.
    PubMed    


  131. DACA-ALVAREZ M, Marti M, Spinelli A, de Miranda NFFC, et al
    Familial component of early-onset colorectal cancer: opportunity for prevention.
    Br J Surg. 2022 Sep 15. pii: 6701677. doi: 10.1093.
    PubMed     Abstract available


  132. FERNANDEZ B, Fleming CA, Marichez A, Mauriac P, et al
    Advances in pelvic exenteration surgery can support clear margin resection for metastatic non-pelvic primary malignancies.
    Br J Surg. 2022;109:1023-1024.
    PubMed    


  133. DAY NM, Kearsey CC, Sutton PA
    Neoadjuvant treatment of advanced colonic cancer: a paradigm shift?
    Br J Surg. 2022;109:895-897.
    PubMed    


  134. YEOW M, Soh S, Wong J, Koh FH, et al
    Transanal tube versus defunctioning stoma after low anterior resection for rectal cancer: network meta-analysis of randomized controlled trials.
    Br J Surg. 2022;109:900-903.
    PubMed    


  135. KIYOZUMI Y, Akiyoshi T, Mukai T, Hiyoshi Y, et al
    Lateral local recurrence after total mesorectal excision for mid/low rectal cancer: study of clinical characteristics and impact of salvage surgery on survival.
    Br J Surg. 2022;109:904-907.
    PubMed    


  136. MAROLI A, Carvello M, Foppa C, Kraft M, et al
    Anxiety as a risk factor for postoperative complications after colorectal surgery: new area for perioperative optimization.
    Br J Surg. 2022;109:898-899.
    PubMed    


    August 2022
  137. KUNITOMO A, Ouchi A, Matsuo K, Komori K, et al
    Clinical significance of surgical intervention for isolated para-aortic lymph node metastasis from colorectal cancer: a time-varying co-variate analysis.
    Br J Surg. 2022 Aug 30. pii: 6678830. doi: 10.1093.
    PubMed    



  138. Colorectal Endoscopic Stenting Trial (CReST) for obstructing left-sided colorectal cancer: randomized clinical trial.
    Br J Surg. 2022 Aug 20. pii: 6672717. doi: 10.1093.
    PubMed     Abstract available


  139. ANDERSEN BT, Kazaryan AM, Stimec BV, Edwin B, et al
    Personalized surgery for the splenic flexure cancer: new frontiers.
    Br J Surg. 2022;109:880-881.
    PubMed    


  140. OLTHOF PB, Buettner S, Andreatos N, Wang J, et al
    KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:804-807.
    PubMed    



  141. Incisional hernia following colorectal cancer surgery according to suture technique: Hughes Abdominal Repair Randomized Trial (HART).
    Br J Surg. 2022 Aug 8. pii: 6656065. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  142. SIJBERDEN JP, Abu Hilal M
    Comment on: Synchronous resection of primary colorectal cancer with liver metastases: two birds with one stone?
    Br J Surg. 2022 Jul 16. pii: 6645296. doi: 10.1093.
    PubMed    


  143. GEORGE AJ, Thomas C, Mathew DE, Jesudasan MR, et al
    Viral RNA in peritoneal, rectal, and blood samples from surgical patients with COVID-19.
    Br J Surg. 2022;109:772.
    PubMed    


  144. FLEMING C, Vendrely V, Rullier E, Denost Q, et al
    Organ preservation in rectal cancer: review of contemporary management.
    Br J Surg. 2022;109:695-703.
    PubMed     Abstract available


  145. PODDA M, Pisanu A, Di Saverio S
    Author response to: Laparoscopic versus open colectomy for locally advanced T4 colonic cancer: meta-analysis of clinical and oncological outcomes.
    Br J Surg. 2022;109:e96.
    PubMed    


  146. WANG X, Zheng Z, Xie Z, Huang S, et al
    Comment on: Laparoscopic versus open colectomy for locally advanced T4 colonic cancer: meta-analysis of clinical and oncological outcomes.
    Br J Surg. 2022;109:e95.
    PubMed    


  147. MORISSON L, Verdonck O, Latulippe JF, Richebe P, et al
    Comment on: Low-pressure versus standard pressure laparoscopic colorectal surgery (PAROS trial): a phase III randomized controlled trial.
    Br J Surg. 2022;109:e93.
    PubMed    


  148. FRANDON J, Berny L, Prudhomme M, de Forges H, et al
    Inferior mesenteric artery embolization ahead of rectal cancer surgery: AMIREMBOL pilot study.
    Br J Surg. 2022;109:650-652.
    PubMed    


    June 2022

  149. Impact of microsatellite status in early-onset colonic cancer.
    Br J Surg. 2022;109:632-636.
    PubMed     Abstract available


  150. NORDKAMP S, Voogt ELK, van Zoggel DMGI, Martling A, et al
    Locally recurrent rectal cancer: oncological outcomes with different treatment strategies in two tertiary referral units.
    Br J Surg. 2022;109:623-631.
    PubMed     Abstract available


  151. ROSEN R, Nilsson E, Rahman M, Ronnow CF, et al
    Accuracy of MRI in early rectal cancer: national cohort study.
    Br J Surg. 2022;109:570-572.
    PubMed    


    May 2022
  152. YAQUB S
    Comment on: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
    Br J Surg. 2022 May 17. pii: 6587119. doi: 10.1093.
    PubMed    


  153. SIRIWARDENA AK
    Author response to: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
    Br J Surg. 2022 May 17. pii: 6586615. doi: 10.1093.
    PubMed    


  154. BJORNELV GMW, Zolic-Karlsson Z, Dueland S, Line PD, et al
    Cost-effectiveness of liver transplantation versus last-resort systemic therapy for colorectal liver metastases.
    Br J Surg. 2022;109:483-485.
    PubMed    


  155. KOTHARI A, White MG, Peacock O, Kaur H, et al
    Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer.
    Br J Surg. 2022;109:489-492.
    PubMed    


    April 2022
  156. VIGANO L, Terrone A, Costa G, Franchi E, et al
    Effect of chemotherapy on tumour-vessel relationship in colorectal liver metastases.
    Br J Surg. 2022;109:401-404.
    PubMed    


  157. VAN DER HEIJDEN JAG, Qaderi SM, Verhoeven R, Custers JAE, et al
    Author response to: Transanal total mesorectal excision and low anterior resection syndrome.
    Br J Surg. 2022;109:e78.
    PubMed    


  158. WALKER ET, McDermott FD, Smart NJ, Daniels IR, et al
    Comment on: Transanal total mesorectal excision and low anterior resection syndrome.
    Br J Surg. 2022;109:e77.
    PubMed    


  159. KOTHARI A, White MG, Peacock O, Kaur H, et al
    Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer.
    Br J Surg. 2022 Apr 4. pii: 6562962. doi: 10.1093.
    PubMed    


    March 2022
  160. SAW KS, Liu C, Xu W, Varghese C, et al
    Corrigendum to: Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis.
    Br J Surg. 2022 Mar 15. pii: 6548412. doi: 10.1093.
    PubMed    


  161. PODDA M, Pisanu A, Morello A, Segalini E, et al
    Laparoscopic versus open colectomy for locally advanced T4 colonic cancer: meta-analysis of clinical and oncological outcomes.
    Br J Surg. 2022;109:319-331.
    PubMed     Abstract available


  162. ZWANENBURG ES, Wisselink DD, Klaver CEL, Brandt ARM, et al
    Adhesion formation after surgery for locally advanced colonic cancer in the COLOPEC trial.
    Br J Surg. 2022;109:315-318.
    PubMed    


  163. LOKUHETTY N, Mohan HM, Kong JC, Heriot AG, et al
    Lateral pelvic sidewall dissection in rectal cancer: case selection and training to optimize outcomes.
    Br J Surg. 2022;109:306-307.
    PubMed    


    February 2022
  164. PATEL A, Spychalski P, Kobiela J
    Short-course radiotherapy and consolidation chemotherapy: in search of a balanced protocol.
    Br J Surg. 2022;109:e50-e51.
    PubMed    



  165. Microsatellite instability in young patients with rectal cancer: molecular findings and treatment response.
    Br J Surg. 2022;109:251-255.
    PubMed    


  166. SOREIDE K
    Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?
    Br J Surg. 2022;109:242-243.
    PubMed    


  167. CAMERON D, Talari A, Rehman I, Mitchell P, et al
    Detecting colorectal cancer using infrared spectroscopy.
    Br J Surg. 2022 Feb 10. pii: 6525757. doi: 10.1093.
    PubMed    


  168. CRISTAUDO AT, Morris DL
    Hypothesis to explain the disparity in the proportion of liver metastases between appendiceal and colorectal cancer.
    Br J Surg. 2022 Feb 8. pii: 6524033. doi: 10.1093.
    PubMed    


  169. SIRIWARDENA AK
    Synchronous resection of primary colorectal cancer with liver metastases: two birds with one stone?
    Br J Surg. 2022 Feb 3. pii: 6521658. doi: 10.1093.
    PubMed    


  170. BRADLEY A, Knight S, Chin MY, Moug S, et al
    Comment on: Permanent stoma rates after anterior resection for rectal cancer: risk prediction scoring using preoperative variables.
    Br J Surg. 2022;109:e39.
    PubMed    


  171. BACK E, Haggstrom J, Holmgren K, Haapamaki MM, et al
    Author response to: Permanent stoma prediction after anterior resection for rectal cancer: risk prediction scoring using preoperative variables.
    Br J Surg. 2022;109:e40.
    PubMed    


  172. VAN DEN HEEDE K, Chidambaram S, Van Slycke S, Brusselaers N, et al
    Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.
    Br J Surg. 2022;109:191-199.
    PubMed     Abstract available


    December 2021
  173. JUNG F, Lee M, Doshi S, Zhao G, et al
    Neoadjuvant therapy versus direct to surgery for T4 colon cancer: meta-analysis.
    Br J Surg. 2021;109:30-36.
    PubMed     Abstract available


  174. DENG X, Wu Q, Bi L, Yu Y, et al
    Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial.
    Br J Surg. 2021;109:121-128.
    PubMed     Abstract available


  175. BAHADOER RR, Peeters KCMJ, Beets GL, Figueiredo NL, et al
    Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years.
    Br J Surg. 2021;109:114-120.
    PubMed     Abstract available


  176. RAJARETNAM N, Smart NJ
    To mesh or not to mesh-the known unknowns of preventing parastomal hernias.
    Br J Surg. 2021;109:1-2.
    PubMed    


  177. SAW KS, Liu C, Xu W, Varghese C, et al
    Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis.
    Br J Surg. 2021 Dec 15. pii: 6462011. doi: 10.1093.
    PubMed     Abstract available


  178. DUELAND S, Syversveen T, Hagness M, Grut H, et al
    Liver transplantation for advanced liver-only colorectal metastases.
    Br J Surg. 2021;108:1402-1405.
    PubMed    


    November 2021
  179. POLSON R, Abdelqader B, Chung WY, Sangal S, et al
    Impact of the COVID-19 pandemic on early outcomes after colorectal cancer surgery.
    Br J Surg. 2021 Nov 11. pii: 6425606. doi: 10.1093.
    PubMed    


  180. CLIFFORD RE, Harji D, Poynter L, Jackson R, et al
    Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study.
    Br J Surg. 2021;108:1270-1273.
    PubMed    


  181. VAN HERWAARDEN YJ, Madani A, van der Post RS, Lemmens VEPP, et al
    Incidental diagnosis of serrated polyp in the appendix warrants colonoscopy to screen for colorectal neoplasia.
    Br J Surg. 2021;108:e373-e374.
    PubMed    


  182. BACK E, Haggstrom J, Holmgren K, Haapamaki MM, et al
    Permanent stoma rates after anterior resection for rectal cancer: risk prediction scoring using preoperative variables.
    Br J Surg. 2021;108:1388-1395.
    PubMed     Abstract available


  183. HOL JC, Burghgraef TA, Rutgers MLW, Crolla RMPH, et al
    Comparison of laparoscopic versus robot-assisted versus transanal total mesorectal excision surgery for rectal cancer: a retrospective propensity score-matched cohort study of short-term outcomes.
    Br J Surg. 2021;108:1380-1387.
    PubMed     Abstract available


    October 2021
  184. KANANI A, Veen T, Soreide K
    Neoadjuvant immunotherapy in primary and metastatic colorectal cancer.
    Br J Surg. 2021 Oct 25. pii: 6409933. doi: 10.1093.
    PubMed     Abstract available


  185. PERDAWOOD SK, Neufert RS, Kroeigaard J, Maina PJ, et al
    Low presence of intraluminal cancer cells in rectal washout during transanal total mesorectal excision.
    Br J Surg. 2021;108:e338-e339.
    PubMed    


  186. TIBERMACINE H, Rouanet P, Sbarra M, Forghani R, et al
    Radiomics modelling in rectal cancer to predict disease-free survival: evaluation of different approaches.
    Br J Surg. 2021;108:1243-1250.
    PubMed     Abstract available


  187. HAAK HE, Beets GL, Peeters K, Nelemans PJ, et al
    Prevalence of nodal involvement in rectal cancer after chemoradiotherapy.
    Br J Surg. 2021;108:1251-1258.
    PubMed     Abstract available


  188. POLSON R, Abdelqadar B, Chung WY, Sangal S, et al
    Impact of the COVID-19 pandemic on early outcomes after colorectal cancer surgery.
    Br J Surg. 2021 Oct 21. pii: 6406949. doi: 10.1093.
    PubMed    


  189. ISMAIEL M, Murphy B, Hayes C, O'Connell LV, et al
    Differential inflammatory profile of mesenteric and omental fat in patients with colorectal cancer.
    Br J Surg. 2021 Oct 6. pii: 6382002. doi: 10.1093.
    PubMed    


  190. DIAMANTIS A, Samara AAlpha, Tzovaras G, Magouliotis D, et al
    Use of preoperative EORTC quality-of-life questionnaires to predict postoperative complications after colorectal cancer surgery.
    Br J Surg. 2021 Oct 3. pii: 6380642. doi: 10.1093.
    PubMed    


    September 2021
  191. ASHRAF H, Anderson RG, Anderson DJ, Moug SJ, et al
    Feasibility of a perioperative smartphone application in colorectal surgery.
    Br J Surg. 2021;108:e282-e283.
    PubMed    


  192. MORINO M, Forcignano E, Arezzo A
    Early clinical adoption of a flexible robotic endoscope for local excision of rectal lesions.
    Br J Surg. 2021;108:e296.
    PubMed    


    August 2021
  193. SOLOMON MJ, Daster S, Loizides S, Sutton P, et al
    Access to the anterior pelvic compartment in pelvic exenteration in women-the interlabial approach: video vignette.
    Br J Surg. 2021;108:e268-e269.
    PubMed    


  194. SUTTON PA, Solomon M, Sasidharan P, Lee P, et al
    Abdominolithotomy sacrectomy for the management of locally recurrent rectal cancer: video vignette.
    Br J Surg. 2021;108:e257.
    PubMed    


  195. WALDRON RM, Moloney BM, Gilligan K, Lowery AJ, et al
    MicroRNAs as biomarkers of multimodal treatment for rectal cancer.
    Br J Surg. 2021;108:e260-e261.
    PubMed    


  196. EL-WAJEH YAM, Askari G, Gordji ME, Mohammed-Ali RI, et al
    Elementary introduction to game theory, rationality and hyper-rationality decision-making: optimizing a surgeon's negotiation strategies.
    Br J Surg. 2021;108:e262-e263.
    PubMed    


  197. VAN DER HEIJDEN JAG, Qaderi SM, Verhoeven R, Custers JAE, et al
    Transanal total mesorectal excision and low anterior resection syndrome.
    Br J Surg. 2021;108:991-997.
    PubMed     Abstract available


  198. KAWAGUCHI Y, Kopetz S, Tran Cao HS, Panettieri E, et al
    Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
    Br J Surg. 2021;108:968-975.
    PubMed     Abstract available


  199. LEE J, Grubac V, Baxter N, Auer R, et al
    Digital rectal examination in palpable rectal cancer: expert panel consensus on key elements and analysis of a case series.
    Br J Surg. 2021;108:e264-e265.
    PubMed    


  200. CELARIER S, Monziols S, Celerier B, Assenat V, et al
    Low-pressure versus standard pressure laparoscopic colorectal surgery (PAROS trial): a phase III randomized controlled trial.
    Br J Surg. 2021;108:998-1005.
    PubMed     Abstract available


    July 2021
  201. ROXBURGH CS
    Organ preservation in rectal cancer: towards the norm rather than the exception.
    Br J Surg. 2021;108:745-747.
    PubMed    


  202. DE LA MOTTE L, Custovic S, Tapper J, Arver S, et al
    Effect of preoperative radiotherapy for rectal cancer on spermatogenesis.
    Br J Surg. 2021;108:750-753.
    PubMed    


  203. D'SOUZA N, Delisle TG, Chen M, Benton SC, et al
    Faecal immunochemical testing in symptomatic patients to prioritize investigation: diagnostic accuracy from NICE FIT Study.
    Br J Surg. 2021;108:804-810.
    PubMed     Abstract available


  204. ISONIEMI H, Uutela A, Nordin A, Lantto E, et al
    Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
    Br J Surg. 2021;108:817-825.
    PubMed     Abstract available


    June 2021
  205. RYOO SB, Park JW, Lee DW, Lee MA, et al
    Anterior resection syndrome: a randomized clinical trial of a 5-HT3 receptor antagonist (ramosetron) in male patients with rectal cancer.
    Br J Surg. 2021;108:644-651.
    PubMed     Abstract available


  206. DENOST Q, Rouanet P, Faucheron JL, Panis Y, et al
    Impact of early biochemical diagnosis of anastomotic leakage after rectal cancer surgery: long-term results from GRECCAR 5 trial.
    Br J Surg. 2021;108:605-608.
    PubMed    


  207. TALBOOM K, Vogel I, Blok RD, Roodbeen SX, et al
    Highly selective diversion with proactive leakage management after low anterior resection for rectal cancer.
    Br J Surg. 2021;108:609-612.
    PubMed    


  208. VOOGT ELK, Nordkamp S, Nieuwenhuijzen GAP, Creemers GJ, et al
    Curative treatment of locally recurrent rectal cancer: is induction chemotherapy warranted?
    Br J Surg. 2021;108:e213-e214.
    PubMed    


    May 2021
  209. SEPPALA TT, Latchford A, Negoi I, Sampaio Soares A, et al
    European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender.
    Br J Surg. 2021;108:484-498.
    PubMed     Abstract available


  210. GRAVERSEN M, Detlefsen S, Pfeiffer P, B Mortensen M, et al
    Local peritoneal toxicity from adjuvant pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in high-risk patients with colonic cancer.
    Br J Surg. 2021;108:e187-e188.
    PubMed    


  211. CREAVIN B, Kelly ME, Ryan EJ, Ryan OK, et al
    Oncological outcomes of laparoscopic versus open rectal cancer resections: meta-analysis of randomized clinical trials.
    Br J Surg. 2021;108:469-476.
    PubMed     Abstract available


  212. CHAKRABARTI D, Rajan S, Akhtar N, Qayoom S, et al
    Short-course radiotherapy with consolidation chemotherapy versus conventionally fractionated long-course chemoradiotherapy for locally advanced rectal cancer: randomized clinical trial.
    Br J Surg. 2021;108:511-520.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.